Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus.
Alobaid SM, Alshahrani RM, Alonazi AS, Alrasheed NM, Alamin MA, Alshammari TK, Bin Dayel AF, Elnagar DM, Alotaibi RR, Almuthnabi LA, Almasud DH, Al-Ammar SE, Almadhi SO, Almalke RA, Aldamri NT, Alghibiwi HK, Alkhelb DA, Alrasheed NM.
Alobaid SM, et al. Among authors: alghibiwi hk.
Pharmaceuticals (Basel). 2024 Mar 15;17(3):374. doi: 10.3390/ph17030374.
Pharmaceuticals (Basel). 2024.
PMID: 38543160
Free PMC article.